Zum Inhalt
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.06.2021 | editorial

Immunotherapy revisited

verfasst von: Assoc. Prof. PD Dr. Thorsten Füreder

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Auszug

Immunotherapy has revolutionized cancer treatment during the last few years. Impressive long-term survival rates (beyond 5 years) even in deadly diseases such as metastatic lung cancer or malignant melanoma were achieved by checkpoint inhibitor (CPI) therapy. …
Nächster Artikel Treatment approaches towards physical activity – malnutrition – cognitive impairment
Literatur
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Metadaten
Titel
Immunotherapy revisited
verfasst von
Assoc. Prof. PD Dr. Thorsten Füreder
Publikationsdatum
01.06.2021
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2021
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00711-7

Weitere Artikel der Ausgabe 2/2021

ESMO virtual congress 2020—highlights NSCLC

  • Open Access
  • short review

WHO classification of tumors of the nervous system: preview of the upcoming 5th edition

  • Open Access
  • short review

Cognitive impairment in cancer patients and survivors—clinical presentation, pathophysiology, diagnosis and management

  • review

Leptomeningeal metastases from solid tumours

  • Open Access
  • short review

Brain metastases: new systemic treatment approaches

  • Open Access
  • short review

Novel immune checkpoints beyond PD-1 in advanced melanoma

  • Open Access
  • short review